| Literature DB >> 30996801 |
Gregorio Cullia1, Stefano Bruno2, Silvia Parapini3, Marilena Margiotta2, Lucia Tamborini1, Andrea Pinto4, Andrea Galbiati1, Andrea Mozzarelli2, Marco Persico5, Antonella Paladino6, Caterina Fattorusso5, Donatella Taramelli7, Paola Conti1.
Abstract
Covalent inhibitors of PfGAPDH characterized by a 3-bromoisoxazoline warhead were developed, and their mode of interaction with the target enzyme was interpreted by means of molecular modeling studies: some of them displayed a submicromolar antiplasmodial activity against both chloroquine sensitive and resistant strains of Plasmodium falciparum, with good selectivity indices.Entities:
Year: 2019 PMID: 30996801 PMCID: PMC6466836 DOI: 10.1021/acsmedchemlett.8b00592
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345